Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
NCT04353778Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Aug 2020
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in small intestinal bacterial overgrowth (SIBO), Vagus nerve dysfunction, sponsored by Icahn School of Medicine at Mount Sinai. Started Aug 2020; status: completed.
02
Drugs
pyridostigmine
03
Conditions
small intestinal bacterial overgrowth (SIBO)Vagus nerve dysfunction
Beyond the preview
Go deeper on NCT04353778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04353778.